Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for early osteonecrosis of the hip
ACTRN12609000104257Phase 2Recruiting
- Sponsor
- University of Sydney
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in osteonecrosis of the hip comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Progression to advanced disease or surgery. Started Apr 2009; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on ACTRN12609000104257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000104257.